TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3611398

Group type: EXPERIMENTAL
Intervention: Lorazepam (4 mg orally)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2667015

Group type: EXPERIMENTAL
Intervention: Desmethylimipramine (DMI) 50 mg oral test dose
Number of subjects: 15

Group type: COMPARATOR
Intervention: Amitriptyline (AMI)
Number of subjects: 15
Study: 31520258

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: No acupuncture therapy (Control)
Number of subjects: 60
Study: 25701102

Group type: EXPERIMENTAL
Intervention: Health coaching intervention delivered by medical students
Number of subjects: 29
Study: 26074402

Group type: EXPERIMENTAL
Intervention: N1b patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N1a patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: pT3b and pT4a tumors with N1b
Number of subjects: 0
Study: 23315596

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 3195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3195
Study: 21702877

Group type: EXPERIMENTAL
Intervention: Infant massage intervention (daily for 10 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19843033

Group type: EXPERIMENTAL
Intervention: Conversion from cyclosporine (CsA) to sirolimus
Number of subjects: 193

Group type: COMPARATOR
Intervention: Continue cyclosporine (CsA)
Number of subjects: 193
Study: 16739838

Group type: EXPERIMENTAL
Intervention: He's Santong needling method
Number of subjects: 319

Group type: COMPARATOR
Intervention: Acupuncture at 12 points of the hand and foot
Number of subjects: 319
Study: 15195986

Group type: EXPERIMENTAL
Intervention: Isometric knee extension strength
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Habitual physical activity (predominantly household work)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timed 'Get‐Up‐and‐Go' test (TGUG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified Coopertest (COOP)
Number of subjects: 0
Study: 11717612

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control (no ramipril)
Number of subjects: 122
Study: 9386211

Group type: EXPERIMENTAL
Intervention: Continuous combined HRT with Kliogest (daily tablet for 9 months)
Number of subjects: 2151

Group type: EXPERIMENTAL
Intervention: Continuous combined HRT with Kliogest
Number of subjects: 2151
Study: 7952793

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol 12.5, 50 and 100 micrograms
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inhaled salbutamol 200 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol 50 and 100 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol and salbutamol
Number of subjects: 8
Study: 2438095

Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and theophylline
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Salbutamol (aerosol nebulizers)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 29035598

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 30% intensity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 60% intensity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at 80% intensity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling at maximal intensity
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Concentric (CONC) cycling
Number of subjects: 10

Group type: COMPARATOR
Intervention: Eccentric (ECC) cycling
Number of subjects: 10
Study: 26397235

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (1.5 mg/kg IV bolus followed by 2 mg/kg/h infusion until end of surgery)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Normal saline (same volume as lidocaine)
Number of subjects: 94
Study: 24534082

Group type: EXPERIMENTAL
Intervention: Supervised exercise program (12-week, thrice weekly)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study: 22948049

Group type: EXPERIMENTAL
Intervention: ABVD chemotherapy
Number of subjects: 287

Group type: COMPARATOR
Intervention: Stanford V chemotherapy
Number of subjects: 287
Study: 20063935

Group type: EXPERIMENTAL
Intervention: Cognitive function assessment (not specified dosage or duration)
Number of subjects: 0
Study: 17400154

Group type: EXPERIMENTAL
Intervention: Angiographic embolization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrinogen or recombinant activated factor VII (rFVIIa)
Number of subjects: 0
Study: 15694083

Group type: COMPARATOR
Intervention: Oral misoprostol 25 microg every 3 days for a maximum of three doses
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Oral misoprostol 50 microg every 3 days for a maximum of three doses
Number of subjects: 49
Study: 12798694

Group type: EXPERIMENTAL
Intervention: RT (Radiation Therapy)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: RT + HYST (Radiation Therapy with Extrafascial Hysterectomy)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: RT + HYST
Number of subjects: 256

Group type: COMPARATOR
Intervention: RT
Number of subjects: 256
Study: 10365928

Group type: EXPERIMENTAL
Intervention: Topical azelaic acid 20% cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical metronidazole 0.75% cream
Number of subjects: 40
Study: 7582291

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study: 1742442

Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model with added variable plot
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model with constructed variable plot
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model
Number of subjects: 0
Study: 6756934

Group type: EXPERIMENTAL
Intervention: Piretanide 1.0 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Frusemide 6.25 mg
Number of subjects: 34
Study: 31551393

Group type: EXPERIMENTAL
Intervention: Accelerated medical assessment and surgical repair with a goal of surgery within 6 hours of diagnosis
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Standard care where a repair typically occurs 24 to 48 hours after diagnosis
Number of subjects: 1998
Study: 29116999

Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration and hemoperfusion
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 110
Study: 26955672

Group type: EXPERIMENTAL
Intervention: Hebi Recipe (HR) plus Methotrexate (MTX)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 63
Study: 24743706

Group type: EXPERIMENTAL
Intervention: Experimental therapies (specific therapies not detailed)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Addition of cetuximab in the KRAS, BRAF wild-type cohort
Number of subjects: 244

Group type: COMPARATOR
Intervention: FOLFIRI chemotherapy (common control arm)
Number of subjects: 244
Study: 23146806

Group type: EXPERIMENTAL
Intervention: Chaiqinchengqi decoction (CQCQD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 19728201

Group type: EXPERIMENTAL
Intervention: Asthma Control Questionnaire (ACQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asthma Control Scoring System (ACSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asthma Control Test (ACT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asthma Therapy Assessment Questionnaire (ATAQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lara Asthma Symptom Scale (LASS)
Number of subjects: 0
Study: 17975232

Group type: EXPERIMENTAL
Intervention: PCEA with meperidine (2 mg/mL) + adrenaline (2 µg/mL)
Number of subjects: 46

Group type: COMPARATOR
Intervention: PCEA with meperidine (2 mg/mL) alone
Number of subjects: 46
Study: 15125570

Group type: EXPERIMENTAL
Intervention: Citric acid in the tablet matrix (10-15%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Citric acid in granule cores
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ibuprofen (model drug)
Number of subjects: 0
Study: 11756070

Group type: EXPERIMENTAL
Intervention: Purified isoflavones (genistein, daidzein, glycitein)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Purified isoflavones (genistein, daidzein)
Number of subjects: 30
Study: 9785597

Group type: EXPERIMENTAL
Intervention: MRI-compatible headholder and modified MR-couch
Number of subjects: 75
Study: 7637825

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) and chemotherapy (ChT) containing cisplatinum and 5-fluorouracil (5-FU)
Number of subjects: 30
Study: 2673161

Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 48

Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 48
Study: 880567

Group type: EXPERIMENTAL
Intervention: Methotrexate high dose (0.06 mg/kg/dose)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Methotrexate low dose (0.2 mg/kg/dose)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Methotrexate high dose and low dose
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 239
Study: 31533443

Group type: EXPERIMENTAL
Intervention: Chair Yoga (CY)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Music Intervention (MI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Chair-Based Exercise (CBE)
Number of subjects: 31
Study: 30311691

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 464

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study: 28419315

Group type: EXPERIMENTAL
Intervention: Higher CSF neutrophil counts among HIV-uninfected patients
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Low CSF to blood glucose ratio among HIV-uninfected patients
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: CSF culture positivity among HIV-uninfected patients
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Blood neutrophilia among HIV-uninfected patients
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: LTA4H promoter polymorphism
Number of subjects: 608
Study: 25240629

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid eye drops (0.5% loteprednol etabonate) 4 times daily for 15 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 75
Study: 22829151

Group type: EXPERIMENTAL
Intervention: RSA-biofeedback group (N = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (treatment as usual, N = 13)
Number of subjects: 26
Study: 20923251

Group type: EXPERIMENTAL
Intervention: DHEP/heparin plaster
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: DHEP plaster
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo plaster
Number of subjects: 430
Study: 19258615

Group type: EXPERIMENTAL
Intervention: Firebreak skin graft
Number of subjects: 79

Group type: COMPARATOR
Intervention: Fasciectomy
Number of subjects: 79
Study: 17464237

Group type: EXPERIMENTAL
Intervention: Isoflavone (75 mg of isoflavone conjugates/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16739361

Group type: EXPERIMENTAL
Intervention: Controlled release oxycodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 11304094

Group type: EXPERIMENTAL
Intervention: Community action intervention involving formation of community committees and utilization of access-point networks to initiate and maintain intervention strategies.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0
Study: 9646650

Group type: EXPERIMENTAL
Intervention: Nasal ketamine 0.25 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nasal ketamine 5 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nasal midazolam
Number of subjects: 60
Study: 8709686

Group type: EXPERIMENTAL
Intervention: AZT plus ddl (400 mg per day)
Number of subjects: 3207

Group type: EXPERIMENTAL
Intervention: AZT plus ddC (2.25 mg per day)
Number of subjects: 3207

Group type: COMPARATOR
Intervention: AZT (600 mg per day) alone
Number of subjects: 3207

Group type: EXPERIMENTAL
Intervention: AZT plus ddl or ddC
Number of subjects: 3207
Study: 2321571

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1500 mg total, three times daily with meals for 5.5 weeks)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 11
Study: 6991089

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 425
Study: 30771684

Group type: EXPERIMENTAL
Intervention: Trapezial Denervation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trapeziectomy
Number of subjects: 45
Study: 28266878

Group type: EXPERIMENTAL
Intervention: Personalisation message (using recipient's first name)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Feedback message (on personal state)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Adapted message (to recipient's value)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Generic health message (control condition)
Number of subjects: 112
Study: 25471276

Group type: EXPERIMENTAL
Intervention: Additional androgen deprivation therapy (ADT)
Number of subjects: 392

Group type: COMPARATOR
Intervention: HDR brachytherapy (HDR-BT) and external beam radiotherapy (EBRT) without ADT
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: HDR-BT and EBRT with ADT
Number of subjects: 392
Study: 23712683

Group type: EXPERIMENTAL
Intervention: Tool held in peripersonal space (near the body; tool held horizontally)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tool held in extrapersonal space (beyond arms' reach; tool held straight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mid-tool practice in a hockey-like game prior to the task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mid-tool practice constrained to extrapersonal space
Number of subjects: 0
Study: 21441418

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 208

Group type: COMPARATOR
Intervention: Fresh-frozen hamstring tendon allograft
Number of subjects: 208
Study: 19587642

Group type: EXPERIMENTAL
Intervention: CP‐800,569 (30‐1,800 mg once daily for 14 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CP‐800,569 (1,800 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CP‐800,569 (higher doses)
Number of subjects: 0
Study: 17802984

Group type: EXPERIMENTAL
Intervention: Comprehensive telephone-based disease management programme including interactive sessions and telephonic helpline.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group managed in the heart failure clinic without additional interventions.
Number of subjects: 50
Study: 15055997

Group type: EXPERIMENTAL
Intervention: Sitaxsentan 100 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TBC3711 (7z)
Number of subjects: 20
Study: 11802677

Group type: EXPERIMENTAL
Intervention: Heart rate biofeedback
Number of subjects: 35

Group type: COMPARATOR
Intervention: Verbal control instructions
Number of subjects: 35
Study: 8616576

Group type: EXPERIMENTAL
Intervention: Ultrasound-directed transbronchial needle aspiration (USTBNA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard transbronchial needle aspiration (TBNA)
Number of subjects: 80
Study: 1467292

Group type: EXPERIMENTAL
Intervention: Acitretin (50 mg/day)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Hydroxychloroquine (400 mg/day)
Number of subjects: 58
Study: 6532139

Group type: EXPERIMENTAL
Intervention: Alcohol intoxication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expectations about intoxication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31339438

Group type: EXPERIMENTAL
Intervention: Exposure to estimated total costs of different screening strategies
Number of subjects: 267

Group type: COMPARATOR
Intervention: No exposure to estimated total costs
Number of subjects: 267
Study: 30011798

Group type: EXPERIMENTAL
Intervention: Familias Unidas for Health and Wellness intervention
Number of subjects: 140
Study: 26525882

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal stent
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard nCPAP-titration
Number of subjects: 8
Study: 24462034

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard medications
Number of subjects: 26
Study: 22990619

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (60-120 mg/day)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 107
Study: 19781131

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100 microg or 4000 IU daily for 6 months)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 17118669

Group type: EXPERIMENTAL
Intervention: Video-assisted thoracic surgery (VATS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 42
Study: 15906590

Group type: EXPERIMENTAL
Intervention: Sustained release formulation of bupropion in fasting state
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Sustained release formulation of bupropion after high fat meal
Number of subjects: 49
Study: 11872895

Group type: EXPERIMENTAL
Intervention: Abciximab bolus of 0.25 mg/kg body weight
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard antithrombotic medication (aspirin, clopidogrel, and heparin) without abciximab
Number of subjects: 74
Study: 10101324

Group type: EXPERIMENTAL
Intervention: Soft biomechanical orthoses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semirigid biomechanical orthoses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no biomechanical orthoses)
Number of subjects: 0
Study: 7536867

Group type: EXPERIMENTAL
Intervention: Population-based longitudinal study of BPH
Number of subjects: 0
Study: 1827602

Group type: EXPERIMENTAL
Intervention: alprazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 0
Study: 7153164

Group type: EXPERIMENTAL
Intervention: Hospitalization
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 30732609

Group type: EXPERIMENTAL
Intervention: Graphical high-in-sugar label shaped like a stop sign
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Text-based warning label
Number of subjects: 512

Group type: COMPARATOR
Intervention: No FOP label (control)
Number of subjects: 512
Study: 28482053

Group type: EXPERIMENTAL
Intervention: Sleep Intervention Program (SIP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Information-only control (IC)
Number of subjects: 42
Study: 26314508

Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT), 40 sessions
Number of subjects: 104

Group type: COMPARATOR
Intervention: Musical and Dancing Therapy (MDT), therapeutic contact-matched
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Group cognitive remediation therapy (CRT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Musical and Dancing Therapy (MDT)
Number of subjects: 104
Study: 23937306

Group type: EXPERIMENTAL
Intervention: Osseus(®) (new bovine xenograft)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bio‐Oss(®) (commercially available bovine xenograft)
Number of subjects: 20
Study: 22265857

Group type: EXPERIMENTAL
Intervention: ICS + pranlukast
Number of subjects: 25

Group type: COMPARATOR
Intervention: ICS + LABA
Number of subjects: 25
Study: 19444058

Group type: EXPERIMENTAL
Intervention: Open-door laminoplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: French-door laminoplasty
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 17456286

Group type: EXPERIMENTAL
Intervention: Print-out of an ultrasound image of their carotid artery showing atherosclerotic plaque alongside an image of a disease-free artery
Number of subjects: 23

Group type: COMPARATOR
Intervention: Routine verbal feedback
Number of subjects: 23
Study: 15179104

Group type: EXPERIMENTAL
Intervention: Breathing correction (group I)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 55
Study: 11293557

Group type: EXPERIMENTAL
Intervention: Encapsulated 50-mg sumatriptan tablets
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional 50-mg sumatriptan tablets
Number of subjects: 56
Study: 9497189

Group type: EXPERIMENTAL
Intervention: Exclusively breast-fed infants
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Predominantly breast-fed infants
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Partially breast-fed infants
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Fully weaned infants
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Partially breast-fed and fully weaned infants
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Exclusively and predominantly breast-fed infants
Number of subjects: 1450
Study: 8071850

Group type: EXPERIMENTAL
Intervention: Butorphanol (0, 0.5, 1.0 or 2.0 mg/70 kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine (10 mg/70 kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Butorphanol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both butorphanol and morphine
Number of subjects: 12
Study: 2964984

Group type: EXPERIMENTAL
Intervention: bezafibrate
Number of subjects: 148

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 148
Study: 30328169

Group type: EXPERIMENTAL
Intervention: Supervised physical conditioning program (60-min session, 3 days/week for the duration of pregnancy)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Supervised physical conditioning program
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no exercise program)
Number of subjects: 120
Study: 28479216

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy and Holistic Health Recovery Program for Malaysia (HHRP-M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Holistic Health Recovery Program for Malaysia (HHRP-M) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0